Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Diabetes Mellitus · Hemophilia A

Takeda

Takeda clinical programs — 335 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Cambridge, USA HQ
1993 Founded
1,617 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Cambridge, USA
Founded
1993
Employees
1,617
Programs
1179
Drugs
359
Patents
1436
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

Takeda projects

335 ClinicalTrials.gov programs sponsored by Takeda.

Takeda has 335 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

335 programs

Clinical programs

Page 4 of 7

  1. Orteronel 300mg BID

    Takeda

    Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors

    phase 2 small molecule terminated

    1 trial

  2. PF-00547659

    Takeda

    Crohn's Disease

    phase 2 small molecule completed

    1 trial

  3. PF-00547659 SC injection

    Takeda

    Crohn's Disease

    phase 2 small molecule completed

    1 trial

  4. PVS-10200

    Takeda

    Peripheral Artery Disease

    phase 2 mab completed

    1 trial

  5. Paclitaxel

    Takeda

    Ovarian Cancer

    phase 2 small molecule completed

    1 trial

  6. Paclitaxel

    Takeda

    Endometrial Neoplasms

    phase 2 small molecule completed

    1 trial

  7. Paclitaxel and TAK-228

    Takeda

    Metastatic Urothelial Cancer

    phase 2 other active

    1 trial

  8. Pacritinib

    Takeda

    Primary Myelofibrosis

    phase 2 mab terminated

    1 trial

  9. Panitumumab

    Takeda

    Squamous Cell Carcinoma of Head and Neck

    phase 2 small molecule completed

    1 trial

  10. Panitumumab + TAS-102

    Takeda

    Colorectal Cancer

    phase 2 small molecule completed

    1 trial

  11. Panitumumab-2003

    Takeda

    Colorectal Carcinoma

    phase 2 small molecule completed

    1 trial

  12. Pevonedistat

    Takeda

    Acute Myeloid Leukemia (AML)

    phase 2 small molecule completed

    2 trials

  13. Pevonedistat

    Takeda

    Myelodysplastic Syndromes (MDS)

    phase 2 small molecule terminated

    1 trial

  14. Pevonedistat-2002

    Takeda

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  15. Pioglitazone

    Takeda

    Chronic Pancreatitis

    phase 2 small molecule completed

    1 trial

  16. Pioglitazone

    Takeda

    Inflammation

    phase 2 small molecule completed

    1 trial

  17. Pioglitazone

    Takeda

    Oxidative Stress

    phase 2 small molecule completed

    1 trial

  18. Pioglitazone

    Takeda

    Depressive Disorder, Major

    phase 2 small molecule completed

    1 trial

  19. Pioglitazone and atorvastatin

    Takeda

    Cardiovascular Diseases

    phase 2 small molecule completed

    1 trial

  20. Pioglitazone and azilsartan

    Takeda

    Diabetes Mellitus

    phase 2 small molecule completed

    1 trial

  21. Placebo

    Takeda

    Essential Hypertension

    phase 2 small molecule completed

    1 trial

  22. Placebo

    Takeda

    Celiac Disease

    phase 2 small molecule completed

    1 trial

  23. Placebo

    Takeda

    Endometriosis

    phase 2 small molecule completed

    2 trials

  24. Placebo

    Takeda

    Ulcerative Colitis

    phase 2 small molecule completed

    1 trial

  25. Placebo

    Takeda

    Primary Immune Thrombocytopenia

    phase 2 small molecule completed

    1 trial

  26. Placebo

    Takeda

    Graft Rejection

    phase 2 mab completed

    1 trial

  27. Placebo

    Takeda

    Narcolepsy Type 2

    phase 2 small molecule completed

    1 trial

  28. Placebo

    Takeda

    Gout

    phase 2 small molecule completed

    1 trial

  29. Ponatinib

    Takeda

    GIST

    phase 2 small molecule completed

    1 trial

  30. Ponatinib

    Takeda

    Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL)

    phase 2 small molecule terminated

    1 trial

  31. Ponatinib

    Takeda

    Myeloid Leukemia, Chronic, Chronic Phase

    phase 2 small molecule completed

    1 trial

  32. Ponatinib

    Takeda

    Chronic Myeloid Leukemia

    phase 2 small molecule completed

    1 trial

  33. Pramlintide+Metreleptin

    Takeda

    Obesity

    phase 2 small molecule terminated

    1 trial

  34. Purified Inactivated Zika Virus Vaccine (PIZV)

    Takeda

    Healthy Volunteers

    phase 2 mab terminated

    1 trial

  35. Ramelteon

    Takeda

    Migraine

    phase 2 small molecule terminated

    1 trial

  36. Ramelteon

    Takeda

    Sleep Disorder

    phase 2 small molecule completed

    1 trial

  37. Ramelteon

    Takeda

    Sleep Disorders, Circadian Rhythm

    phase 2 small molecule completed

    1 trial

  38. Ramelteon and Placebo (25 possible combinations total)

    Takeda

    Chronic Insomnia

    phase 2 small molecule completed

    1 trial

  39. Ramelteon and doxepin

    Takeda

    Sleep Initiation and Maintenance Disorders

    phase 2 small molecule completed

    1 trial

  40. Ramelteon and gabapentin

    Takeda

    Sleep Initiation and Maintenance Disorders

    phase 2 small molecule completed

    1 trial

  41. Ramelteon or Placebo

    Takeda

    Sleep Apnea, Obstructive

    phase 2 small molecule completed

    1 trial

  42. Recombinant human Arylsulfatase A (rhASA)

    Takeda

    Late Infantile Metachromatic Leukodystrophy

    phase 2 mab completed

    1 trial

  43. Recombinant human arylsulfatase A

    Takeda

    Metachromatic Leukodystrophy (MLD)

    phase 2 mab completed

    1 trial

  44. Recombinant human heparan N-sulfatase (rhHNS)

    Takeda

    Mucopolysaccharidosis (MPS)

    phase 2 mab completed

    1 trial

  45. Recombinant human heparan N-sulfatase [rhHNS]

    Takeda

    Sanfilippo Syndrome

    phase 2 small molecule completed

    1 trial

  46. Recombinant human hyaluronidase + immune globulin intravenous

    Takeda

    Primary Immunodeficiency Diseases (PID)

    phase 2 mab completed

    1 trial

  47. Relugolix

    Takeda

    Prostate Cancer

    phase 2 small molecule completed

    1 trial

  48. Replagal (agalsidase alfa)

    Takeda

    Fabry Disease

    phase 2 mab completed

    1 trial

Frequently asked questions

How many clinical projects does Takeda have?

335 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.